Vaccination Response & Mental Health | Lower Antibody Production

Immune Dysfunction Linked to Psychiatric Disorders: A New Frontier in Mental Health

A growing body of research suggests a profound connection between the immune system and mental health, potentially reshaping our understanding and treatment of conditions like depression, schizophrenia, and psychosis. Psychiatrist and researcher Livia De Picker began investigating this link during the COVID-19 pandemic, observing that patients with pre-existing psychiatric conditions were disproportionately vulnerable to severe illness and death from the virus. This observation spurred a dedicated investigation into the immune function of individuals with mental health disorders.

The Pandemic’s Catalyst for Research

De Picker, who began working at the Duffel University Psychiatric Center in Belgium in 2021, successfully advocated for the prioritization of psychiatric patients in Europe’s COVID-19 vaccination rollout. Early reports from China indicated a heightened risk for those with mental vulnerabilities, prompting her to explore whether a disrupted immune system played a role. “I will only get this chance once,” she recalled thinking as her patients began receiving vaccinations, recognizing a unique opportunity to study the interplay between immunity and mental wellbeing.

Disrupted Immune Responses in Psychiatric Patients

Her research team collected blood samples from patients and staff before and after each dose of the COVID-19 vaccine. The findings revealed a significant difference: individuals with serious psychiatric disorders – including severe depression, schizophrenia, and psychosis – produced fewer antibodies after vaccination compared to those without such conditions. This suggests a fundamental disruption in their immune systems. De Picker, who earned her PhD in 2020 researching psychosis and inflammation, noted she had “long suspected” this connection, and her clinical observations increasingly supported this hypothesis. She identified a subtype of depression that appeared to be “immune-driven,” earning her research an award from EOS Psyche & Brain in September.

A Two-Pronged Immune System Imbalance

De Picker’s study revealed a specific pattern of immune dysfunction. The “first line of defense” – the innate immune system, providing a rapid, broad response to infections – was overactive in psychiatric patients. Conversely, the “second line of defense” – the adaptive immune system, which develops antibodies specifically targeting pathogens and kicks in weeks later – was weaker. This imbalance suggests a compromised ability to mount a targeted and sustained immune response.

Cause and Effect: A Complex Relationship

Determining whether a psychiatric disorder causes immune dysfunction, or vice versa, is a central question. De Picker believes the relationship is bidirectional, with a “causal effect” in both directions. She points to studies showing that treatments designed to boost the immune system, such as interferon used to treat hepatitis C, can induce depression in a significant percentage of patients.

This connection is particularly evident in a specific subgroup of patients experiencing depression with atypical symptoms. These individuals often present with profound fatigue, increased appetite and weight gain, and excessive sleepiness – symptoms that don’t respond well to traditional antidepressants. This subtype exhibits “immunological dysregulation” and elevated levels of inflammation, aligning with research led by Professor Brenda Penninx in Amsterdam. Approximately one-third of people with depression fall into this category.

How Immune Dysfunction Manifests as Psychological Distress

The overactive innate immune system releases substances called cytokines, which can induce feelings of tiredness, grogginess, and depression. While this “illness behavior” is beneficial during an acute infection, conserving energy for the body’s defense, it becomes problematic when the immune system remains chronically activated. This sustained inflammation can affect the brain, activating microglia – immune cells within the brain – and disrupting the production of crucial neurotransmitters like dopamine and serotonin, which regulate energy, motivation, and mood.

The Roots of Immune Disruption

Multiple factors can contribute to immune system disruption. These include lifestyle choices, autoimmune conditions (such as psoriasis, type 1 diabetes, and rheumatism), and infections. Individuals with autoimmune diseases are at a higher risk of developing psychiatric conditions, and treating the autoimmune disease often alleviates the depression. Infections, particularly COVID-19, have also highlighted this link, with a significant proportion of those infected experiencing long-term psychological symptoms like depression, anxiety, and sleep disturbances. The tendency to search for a single viral cause for conditions like chronic fatigue syndrome (ME/CFS) has been a “big mistake,” as any infection, or repeated exposure to infections, can potentially trigger these long-term effects. A Scandinavian study indicated that individuals frequently hospitalized for infections in childhood have a higher risk of developing psychiatric disorders later in life.

The Role of Stress

Stress can temporarily exacerbate immune dysfunction and contribute to depressive symptoms, potentially by interfering with the initial immune response. A study conducted by De Picker’s team involved individuals with a history of depression and healthy volunteers who received a typhoid vaccination, followed by a stressful mental arithmetic test performed in front of evaluators. Only those with a prior history of depression exhibited both immune activation and a temporary dip in mood following the stressor, suggesting a heightened vulnerability to the interplay between stress and immune function.

Future Treatments and Ongoing Research

While the evidence is mounting, De Picker cautions that more research is needed before anti-inflammatory treatments can be widely applied to individuals with depression. Her team is currently conducting a study with 240 patients, classifying them based on their levels of C-reactive protein (CRP), an indicator of inflammation. Participants are randomly assigned to receive celecoxib (an anti-inflammatory painkiller), minocycline (an antibiotic that stabilizes brain immune cells), or a placebo, with results expected in 2028. A similar study is underway in Amsterdam.

Shifting Perspectives in Psychiatry

De Picker’s findings are generating considerable interest within the psychiatric community, particularly among younger colleagues. However, skepticism remains, with some clinicians prioritizing psychological, social, or purely biological explanations for mental illness. De Picker emphasizes that these factors are interconnected, and a holistic approach is essential. She also notes that neurologists and internists sometimes prematurely refer patients with unexplained symptoms to psychiatrists, assuming a psychological origin.

Patients, however, are largely receptive to these findings, finding validation in a potential biological explanation for their experiences. A colleague in the United Kingdom offering immune-based treatments for psychiatric problems is reportedly overwhelmed with patients. De Picker believes framing psychiatric disorders as stemming from a dysregulated immune system reduces stigma, shifting the perception from a “weakness” or “personal failure” to a legitimate medical condition.

Prioritizing Mental Wellbeing: A Personal Approach

De Picker prioritizes her own mental health through a combination of physical activity and mindful self-care. She works at a standing desk, engages in strength training and running, and crucially, allows herself to rest and recover fully when experiencing even minor infections. “That lethargic feeling is the message from your immune system: save your energy, I need it now,” she explains. “Don’t give up and bite the bullet. Listen to your body.”